Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymph Nodes | 13 | 2022 | 3466 | 1.380 |
Why?
|
Ureteral Obstruction | 1 | 2021 | 293 | 0.680 |
Why?
|
Kidney | 5 | 2023 | 7049 | 0.630 |
Why?
|
Glomerulonephritis | 1 | 2018 | 337 | 0.550 |
Why?
|
Reperfusion Injury | 2 | 2019 | 1023 | 0.500 |
Why?
|
Podocytes | 1 | 2019 | 405 | 0.480 |
Why?
|
Fibroblasts | 4 | 2022 | 4140 | 0.440 |
Why?
|
Stromal Cells | 4 | 2022 | 1330 | 0.410 |
Why?
|
Membrane Glycoproteins | 2 | 2021 | 3702 | 0.390 |
Why?
|
Acute Kidney Injury | 2 | 2019 | 1924 | 0.340 |
Why?
|
Transplants | 2 | 2021 | 206 | 0.310 |
Why?
|
Graft Survival | 5 | 2022 | 3819 | 0.290 |
Why?
|
Heart Transplantation | 5 | 2021 | 3234 | 0.270 |
Why?
|
Fibrosis | 4 | 2021 | 2048 | 0.260 |
Why?
|
Lymphotoxin beta Receptor | 2 | 2021 | 25 | 0.230 |
Why?
|
Drug Carriers | 2 | 2018 | 706 | 0.230 |
Why?
|
Mice, Inbred C57BL | 9 | 2022 | 22163 | 0.210 |
Why?
|
CD40 Ligand | 1 | 2022 | 523 | 0.180 |
Why?
|
Nanomedicine | 2 | 2023 | 290 | 0.180 |
Why?
|
Receptors, Leptin | 1 | 2022 | 350 | 0.180 |
Why?
|
Immunity | 3 | 2022 | 997 | 0.170 |
Why?
|
Lymphatic System | 1 | 2021 | 254 | 0.170 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 618 | 0.170 |
Why?
|
Serpins | 1 | 2020 | 247 | 0.160 |
Why?
|
Endothelium, Lymphatic | 1 | 2018 | 63 | 0.160 |
Why?
|
Interleukin-6 | 2 | 2019 | 3207 | 0.150 |
Why?
|
Lymphatic Vessels | 2 | 2022 | 358 | 0.150 |
Why?
|
Graft Rejection | 3 | 2021 | 4445 | 0.150 |
Why?
|
Mice | 15 | 2023 | 81509 | 0.140 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2020 | 1351 | 0.140 |
Why?
|
Animals | 20 | 2023 | 168441 | 0.140 |
Why?
|
Pancreas | 2 | 2023 | 1690 | 0.130 |
Why?
|
T-Lymphocytes | 5 | 2022 | 10194 | 0.130 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2018 | 694 | 0.130 |
Why?
|
Capillaries | 1 | 2018 | 755 | 0.130 |
Why?
|
Nanoparticles | 4 | 2019 | 1955 | 0.120 |
Why?
|
Tacrolimus | 1 | 2018 | 733 | 0.120 |
Why?
|
Extracellular Matrix | 2 | 2022 | 1725 | 0.120 |
Why?
|
Drug Delivery Systems | 3 | 2023 | 2225 | 0.120 |
Why?
|
Thrombotic Microangiopathies | 1 | 2016 | 123 | 0.120 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2018 | 481 | 0.120 |
Why?
|
Kidney Diseases | 2 | 2023 | 2092 | 0.120 |
Why?
|
Membrane Proteins | 2 | 2021 | 7856 | 0.110 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 1960 | 0.110 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18247 | 0.110 |
Why?
|
Skin Transplantation | 1 | 2019 | 1083 | 0.110 |
Why?
|
Creatinine | 1 | 2019 | 1899 | 0.110 |
Why?
|
Dendritic Cells | 3 | 2018 | 2746 | 0.110 |
Why?
|
Leukocytes | 1 | 2021 | 2028 | 0.110 |
Why?
|
Venules | 2 | 2022 | 161 | 0.100 |
Why?
|
Cell Movement | 2 | 2021 | 5203 | 0.100 |
Why?
|
Organ Transplantation | 1 | 2021 | 1157 | 0.090 |
Why?
|
Cytokines | 2 | 2023 | 7392 | 0.090 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 5490 | 0.090 |
Why?
|
Biocompatible Materials | 1 | 2019 | 1685 | 0.090 |
Why?
|
Mice, Inbred BALB C | 4 | 2022 | 6215 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2019 | 2300 | 0.090 |
Why?
|
Up-Regulation | 1 | 2019 | 4124 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1588 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3441 | 0.080 |
Why?
|
Neovascularization, Pathologic | 1 | 2018 | 2644 | 0.080 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2695 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 3077 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2018 | 1726 | 0.070 |
Why?
|
Neoplasms | 3 | 2022 | 22164 | 0.070 |
Why?
|
Mice, Inbred NOD | 2 | 2023 | 1827 | 0.070 |
Why?
|
Signal Transduction | 4 | 2022 | 23441 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2018 | 4370 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4650 | 0.060 |
Why?
|
Inflammation | 5 | 2023 | 10762 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 4575 | 0.060 |
Why?
|
Mice, Knockout | 4 | 2020 | 14409 | 0.050 |
Why?
|
Dendritic Cells, Follicular | 1 | 2022 | 50 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15838 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5365 | 0.050 |
Why?
|
STAT5 Transcription Factor | 1 | 2021 | 264 | 0.040 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 306 | 0.040 |
Why?
|
Chemokine CCL19 | 1 | 2019 | 35 | 0.040 |
Why?
|
Chemokine CCL21 | 1 | 2019 | 50 | 0.040 |
Why?
|
Endothelium | 1 | 2022 | 765 | 0.040 |
Why?
|
Granzymes | 1 | 2020 | 277 | 0.040 |
Why?
|
Methacrylates | 1 | 2019 | 109 | 0.040 |
Why?
|
Lymphotoxin-alpha | 1 | 2018 | 95 | 0.040 |
Why?
|
Organ Preservation | 1 | 2021 | 382 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 174 | 0.040 |
Why?
|
Tissue Adhesives | 1 | 2019 | 173 | 0.040 |
Why?
|
Gelatin | 1 | 2019 | 220 | 0.040 |
Why?
|
Hormones | 1 | 2021 | 869 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2019 | 348 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 39975 | 0.040 |
Why?
|
Perfusion | 1 | 2021 | 1373 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1132 | 0.030 |
Why?
|
Transplantation Tolerance | 1 | 2021 | 605 | 0.030 |
Why?
|
Cell Line | 2 | 2022 | 15605 | 0.030 |
Why?
|
Humans | 13 | 2023 | 761423 | 0.030 |
Why?
|
Sirolimus | 1 | 2022 | 1533 | 0.030 |
Why?
|
Premedication | 1 | 2016 | 247 | 0.030 |
Why?
|
Male | 5 | 2019 | 360736 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 732 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2018 | 859 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2469 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1088 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2124 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2019 | 725 | 0.030 |
Why?
|
Lymphocytes | 1 | 2022 | 2611 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1870 | 0.030 |
Why?
|
Complement Activation | 1 | 2016 | 452 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2667 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2020 | 16979 | 0.030 |
Why?
|
Spleen | 1 | 2018 | 2295 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11902 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2023 | 3061 | 0.020 |
Why?
|
Paclitaxel | 1 | 2018 | 1732 | 0.020 |
Why?
|
Preoperative Care | 1 | 2019 | 2242 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3602 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3159 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4808 | 0.020 |
Why?
|
Swine | 1 | 2019 | 5914 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2416 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5868 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3541 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 1943 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3874 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2811 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10766 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9535 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9418 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11073 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4172 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10441 | 0.020 |
Why?
|
Apoptosis | 1 | 2020 | 9488 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4430 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13502 | 0.010 |
Why?
|
Female | 5 | 2020 | 392581 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5709 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13637 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21012 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 64651 | 0.010 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_